関連する実験動画
Updated: Jun 25, 2026

07:50
Assay Development for High-Throughput Drug Screening Against Mycobacteria
Published on: October 25, 2024
メロペネム・クラヴルナートは,薬剤耐性の高いMycobacterium tuberculosisに対して有効である
Jean-Emmanuel Hugonnet1, Lee W Tremblay, Helena I Boshoff
1Department of Biochemistry, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA.
まとめ
ベータ・ラクタム抗生物質は,BlaC酵素によるMycobacterium tuberculosisに対して失敗する. メロペネムとクラヴルナートを併用すると,薬剤耐性結核菌株に対して強力な活性を示します.
科学分野:
- 微生物学 微生物学とは
- 構造生物学 構造生物学とは
- ドラッグ・ディスカバリー・ディスカバリー・ドラッグ・ディスカバリー・ドラッグ・ディスカバリー
背景:
- ベータ・ラクタム系抗生物質は,Mycobacterium tuberculosisに対して無効である. Mycobacterium tuberculosis. Mycobacterium tuberculosis. Mycobacterium tuberculosis. Mycobacterium tuberculosis. Mycobacterium tuberculosis. Mycobacterium tuberculosis. Mycobacterium tuberculosis. Mycobacterium tuberculosis. Mycobacterium tuberculosis. Mycobacterium tuberculosis. Mycobacterium tuberculosis. Mycobacterium tuberculosis. Mycobacterium tuberculosis. Mycobacterium tuberculosis. Mycobacterium tuberculosis. Mycobacterium tuberculosis. Mycobacterium tuberculosis. Mycobacterium tuberculosis. Mycobacterium tuberculosis. Mycobacterium tuberculosis. Mycobacterium tuberculosis. Mycobacterium tuberculosis. Mycobacterium tuberculosis.
- blaC遺伝子は,これらの抗生物質を素早く水分解するβ-ラクタマースをコードする.
- カーバペネムクラスのβ-乳酸塩は,BlaC.の弱い基質である.
研究 の 目的:
- BlaC-メロペネム複合体の構造を決定する.
- M. tuberculosisに対するクラヴルナートと組み合わせたメロペネムの有効性を評価する.
主な方法:
- X線結晶学を用いて,1.8アングストームの解像度で BlaC-メロペネム共振複合体の3D構造を決定した.
- 最低抑制濃度 (MIC) アッセイは,メロペネムとクラヴルナートのM. tuberculosisに対する活性性を評価するために実施されました.
- 培養物は,異なる生理学的状態を模倣するために,有酸素および無酸素条件下で育てられました.
主要な成果:
- 協和 BlaC-メロペネム複合体の3次元構造が決定されました.
- メロペネムとクラヴルナートを併用したメロペネムは,M. tuberculosis (MIC < 1 μg/mL) に対する強力な活性を示した.
- この組み合わせは14日以内に有酸素培養物の滅菌を達成し,持続的な無酸素培養物を抑制しました.
- 薬剤耐性の高い13種のM.結核菌株に対して活性が観察され,感受性の高い菌株と同等であった.
結論:
- メロペネムは,β-ラクタマース阻害剤クラヴルナートと組み合わせると,M. tuberculosisに対する有望な治療戦略です.
- この組み合わせは,薬剤感受性および広範な薬剤耐性結核の患者を治療する可能性を示しています.
- メロペネムとクラヴルナートの食品医薬品局承認は,潜在的な臨床応用を容易にする.
関連する概念動画
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Antimicrobial Effectiveness
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
